Correlation Between Champions Oncology and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Champions Oncology and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Acrivon Therapeutics,.
Diversification Opportunities for Champions Oncology and Acrivon Therapeutics,
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Champions and Acrivon is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Champions Oncology i.e., Champions Oncology and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Champions Oncology and Acrivon Therapeutics,
Given the investment horizon of 90 days Champions Oncology is expected to generate 0.77 times more return on investment than Acrivon Therapeutics,. However, Champions Oncology is 1.31 times less risky than Acrivon Therapeutics,. It trades about 0.08 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.1 per unit of risk. If you would invest 398.00 in Champions Oncology on August 28, 2024 and sell it today you would earn a total of 20.00 from holding Champions Oncology or generate 5.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Champions Oncology |
| Acrivon Therapeutics, |
Champions Oncology and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Acrivon Therapeutics,
The main advantage of trading using opposite Champions Oncology and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Champions Oncology vs. Fonar | Champions Oncology vs. Burning Rock Biotech | Champions Oncology vs. Sera Prognostics | Champions Oncology vs. Exagen Inc |
| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |